AKT1 and lung cancer: Irisin appears to be beneficial in lung cancer by reversing the activity of EMT through the PI3K/AKT pathway, which may be useful in controlling the proliferation, invasion, and migration of lung cancer and controlling cancer progression (Shao et al., 2017b).